Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure Second (LOVE-HF-2)

NCT04787393 is registered in ClinicalTrials.gov with Heartfelt Technologies as lead sponsor.

NCT NCT04787393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04787393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure Second (LOVE-HF-2)
Lead sponsor
Heartfelt Technologies
Phase
Observational
Overall status
Completed
Start date
June 7, 2022
Completion date
October 26, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure